These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25536850)

  • 1. Detecting a quasi-stable imine species on the reaction pathway of SHV-1 β-lactamase and 6β-(hydroxymethyl)penicillanic acid sulfone.
    Che T; Rodkey EA; Bethel CR; Shanmugam S; Ding Z; Pusztai-Carey M; Nottingham M; Chai W; Buynak JD; Bonomo RA; van den Akker F; Carey PR
    Biochemistry; 2015 Jan; 54(3):734-43. PubMed ID: 25536850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulbactam forms only minimal amounts of irreversible acrylate-enzyme with SHV-1 beta-lactamase.
    Totir MA; Helfand MS; Carey MP; Sheri A; Buynak JD; Bonomo RA; Carey PR
    Biochemistry; 2007 Aug; 46(31):8980-7. PubMed ID: 17630699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: Raman crystallographic evidence.
    Kalp M; Totir MA; Buynak JD; Carey PR
    J Am Chem Soc; 2009 Feb; 131(6):2338-47. PubMed ID: 19161282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone.
    Papp-Wallace KM; Bethel CR; Gootz TD; Shang W; Stroh J; Lau W; McLeod D; Price L; Marfat A; Distler A; Drawz SM; Chen H; Harry E; Nottingham M; Carey PR; Buynak JD; Bonomo RA
    Biochem Pharmacol; 2012 Feb; 83(4):462-71. PubMed ID: 22155308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of E166 in the imine to enamine tautomerization of the clinical beta-lactamase inhibitor sulbactam.
    Kalp M; Buynak JD; Carey PR
    Biochemistry; 2009 Nov; 48(43):10196-8. PubMed ID: 19791797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitors.
    Kalp M; Bethel CR; Bonomo RA; Carey PR
    Biochemistry; 2009 Oct; 48(41):9912-20. PubMed ID: 19736945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase.
    Padayatti PS; Helfand MS; Totir MA; Carey MP; Carey PR; Bonomo RA; van den Akker F
    J Biol Chem; 2005 Oct; 280(41):34900-7. PubMed ID: 16055923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallography.
    Helfand MS; Totir MA; Carey MP; Hujer AM; Bonomo RA; Carey PR
    Biochemistry; 2003 Nov; 42(46):13386-92. PubMed ID: 14621983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
    Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
    Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
    Helfand MS; Taracila MA; Totir MA; Bonomo RA; Buynak JD; van den Akker F; Carey PR
    Biochemistry; 2007 Jul; 46(29):8689-99. PubMed ID: 17595114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence.
    Totir MA; Cha J; Ishiwata A; Wang B; Sheri A; Anderson VE; Buynak J; Mobashery S; Carey PR
    Biochemistry; 2008 Apr; 47(13):4094-101. PubMed ID: 18324783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical investigation on reaction of sulbactam with wild-type SHV-1 β-lactamase: acylation, tautomerization, and deacylation.
    Li R; Liao JM; Gu CR; Wang YT; Chen CL
    J Phys Chem B; 2011 Sep; 115(34):10298-310. PubMed ID: 21797222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why tazobactam and sulbactam have different intermediates population with SHV-1 β-lactamase: a molecular dynamics study.
    Li R; Wang YT; Chen CL
    J Mol Model; 2013 Jun; 19(6):2519-24. PubMed ID: 23455927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam.
    Shapiro AB
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis.
    Tassoni R; Blok A; Pannu NS; Ubbink M
    Biochemistry; 2019 Feb; 58(7):997-1009. PubMed ID: 30632739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penam sulfones and β-lactamase inhibition: SA2-13 and the importance of the C2 side chain length and composition.
    Rodkey EA; Winkler ML; Bethel CR; Pagadala SR; Buynak JD; Bonomo RA; van den Akker F
    PLoS One; 2014; 9(1):e85892. PubMed ID: 24454944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structure-based analysis of the inhibition of class A beta-lactamases by sulbactam.
    Imtiaz U; Billings EM; Knox JR; Mobashery S
    Biochemistry; 1994 May; 33(19):5728-38. PubMed ID: 8180199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structure.
    Padayatti PS; Helfand MS; Totir MA; Carey MP; Hujer AM; Carey PR; Bonomo RA; van den Akker F
    Biochemistry; 2004 Feb; 43(4):843-8. PubMed ID: 14744126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of a preacylation complex of the β-lactamase inhibitor sulbactam bound to a sulfenamide bond-containing thiol-β-lactamase.
    Rodkey EA; Drawz SM; Sampson JM; Bethel CR; Bonomo RA; van den Akker F
    J Am Chem Soc; 2012 Oct; 134(40):16798-804. PubMed ID: 22974281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.